With pharma R&D teams under pressure to turn AI into usable science, Helical lands €8.4 million

London-based Helical, a virtual AI lab for pharma R&D, has announced a €8.4 million ($10 million) Seed round to close the gap between computational predictions and biological decision-making, so teams that traditionally worked in silos can collaborate on the same evidence. The round was led by redalpine with participation from